eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2023
vol. 18
 
Share:
Share:
abstract:
Research paper

Long-lasting dyspeptic symptoms – another consequence of the COVID-19 pandemic?

Anna Nazarewska
1
,
Konrad Lewandowski
1
,
Magdalena Kaniewska
1
,
Edyta Tulewicz-Marti
1
,
Martyna Więcek
1
,
Paulina Szwarc
1
,
Mariusz Rosołowski
2, 3
,
Wojciech Marlicz
4
,
Grażyna Rydzewska
1, 5

  1. Clinical Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Unit, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland
  2. Department of Internal Medicine and Hypertension, Medical University of Bialystok, Bialystok, Poland
  3. Department of Hypertension, Gastroenterology, and Internal Medicine, Medical University of Bialystok Clinical Hospital, Bialystok, Poland
  4. Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland
  5. Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Gastroenterology Rev 2023; 18 (2): 175–182
Online publish date: 2023/07/27
View full text Get citation
 
PlumX metrics:
Introduction
It is known that the virus SARS-CoV-2 can attack the gastrointestinal (GI) tract and induce gastroenteritis. This can trigger a wide variety of disorders of gut-brain interaction (DGBIs) or functional gastrointestinal disorders (FGIDs), including post-infectious dyspepsia, which remains underestimated.

Aim
To estimate the prevalence of dyspeptic symptoms following COVID-19, immediately after discharge and 3, 6, and 9 months after hospitalization.

Material and methods
A prospective, single-centre evaluation of questions regarding functional dyspepsia (FD) as assessed by the Gastroduodenal Module of ROME IV Diagnostic Questionnaire for Adult FGIDs among 320 patients who had had COVID-19.

Results
The FD ROME IV criteria were met at the respective time-points by 0.0% (0), 4.8% (12), 3.2% (8), and 3.2% (8) of cases. However, the presence of GI symptoms that suggested FD but did not meet the timeframe ROME IV criteria for FD were found in 9.6% (24), 23.5% (59), 20.7% (52), and 20.7% (52) of cases, respectively.

Conclusions
The presence and persistence of gastrointestinal dyspeptic symptoms following COVID-19 is a significant problem. The timeframe of the Rome IV criteria may underestimate the number of patients with persistent dyspeptic symptoms following COVID-19 disease.

keywords:

functional gastrointestinal disorders, disorders of gut-brain interaction, functional dyspepsia, coronavirus disease 2019, ROME IV criteria

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.